Dec 6, 2024 · Despite observing a steep decline in prices and underperforming the Dow Jones Industrial Average over the past year, analysts remain strongly bullish on Elevance Health’s prospects.

Elevance Health Inc. stock underperforms Thursday when compared to competitors ... with the S&P 500 Index SPX rising 0.36% to 6,083.57 and the Dow Jones Industrial Average DJIA falling 0.28% to ...

Complete Elevance Health Inc. stock information by Barron's. View real-time ELV stock price and news, along with industry-best analysis.

Elevance Health Inc. research and ratings by Barron's. View ELV revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Jan 30, 2024 · Elevance Health, Inc. (ELV) is currently at $491.82, up $5.29 or 1.09% --Would be highest close since April 13, 2023, when it closed at $496.20. --Currently up seven consecutive days; up 5.86%...

Shares of Elevance Health Inc. ELV rallied 2.38% to $405.10 Monday, ... with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow Jones Industrial Average DJIA falling 0.28% to 44,421.91. ...

Shares of Elevance Health Inc. ELV advanced 1.03% to $526.52 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 2.30% to...

Jul 20, 2023 · Elevance's top line was pushed higher by growth in premium revenue from the health benefits business and higher pharmacy product revenue from CarelonRx, due in part to its acquisition of BioPlus in...

Elevance Health Inc. stock grades by Barron's. View ELV fundamental and sentiment analysis powered by MarketGrader.

19 hours ago · CNBC’s Jim Cramer on Thursday thought it worthwhile to review ten stocks that led the Dow Jones Industrial Average over the past year, including 3M and Amgen.